Clinical Trials Sponsored by Frontier Medicines Corporation
Total 217 results
-
Frontier Medicines CorporationRecruitingColorectal Cancer | Pancreatic Cancer | Non Small Cell Lung Cancer | Metastatic Solid Tumor | Solid Tumor, Adult | Unresectable Solid Tumor | KRAS G12C | Advanced Solid Tumors With KRAS G12C MutationsUnited States
-
Medecins Sans Frontieres, SpainCompletedTuberculosisGuinea-Bissau, South Sudan
-
Medecins Sans Frontieres, NetherlandsTerminatedCutaneous LeishmaniasesPakistan
-
Medecins Sans Frontieres, NetherlandsCompletedPost-kala-azar Dermal Leishmaniasis
-
Medecins Sans Frontieres, SpainCompletedChild Malnutrition | Infant MorbidityUganda
-
Medecins Sans Frontieres, NetherlandsUnknownOld World Cutaneous Leishmaniasis
-
Medecins Sans Frontieres, NetherlandsCompleted
-
Medecins Sans Frontieres, NetherlandsCompleted
-
Medecins Sans Frontieres, NetherlandsCompletedWeight Loss | Malaria | Weight Gain | ConvalescenceCongo
-
Medecins Sans Frontieres, NetherlandsCompletedMalnutrition | Malaria | Lower Respiratory Tract Infection | DiarrhoeaNigeria
-
EpicentreMedecins Sans Frontieres, NetherlandsCompleted
-
EpicentreMedecins Sans Frontieres, NetherlandsWithdrawn
-
EpicentreMedecins Sans Frontieres, NetherlandsCompletedTuberculosis | Multi Drug Resistant TuberculosisUganda
-
EpicentreMedecins Sans Frontieres, NetherlandsCompleted
-
EpicentreMedecins Sans Frontieres, NetherlandsCompleted
-
Blueprint Medicines CorporationRecruitingCNS Tumor | Solid Tumor, Unspecified, Child | Relapsed Solid NeoplasmUnited States, Korea, Republic of, United Kingdom, France, Canada, Australia, Austria, Germany, Italy
-
Blueprint Medicines CorporationTerminatedNeoplasms | Respiratory Tract Diseases | Neoplasms by Histologic Type | Lung Diseases | Neoplasms by Site | Adenocarcinoma | Carcinoma | Carcinoma, Non-Small-Cell Lung | Respiratory Tract Neoplasms | Thoracic Neoplasms | Carcinoma, Bronchogenic | Bronchial Neoplasms | Neoplasms, Nerve Tissue | Non Small Cell Lung... and other conditionsUnited States
-
Blueprint Medicines CorporationActive, not recruitingIndolent Systemic MastocytosisCanada, United States, Spain, United Kingdom, Germany, Belgium, Switzerland, Italy, Netherlands, Denmark, France, Norway, Sweden
-
Blueprint Medicines CorporationCompletedMast Cell Leukemia | Aggressive Systemic Mastocytosis | Systemic Mastocytosis-associated Hematologic Non-mast Cell Disease | Relapsed or Refractory Myeloid MalignanciesUnited States, United Kingdom
-
Blueprint Medicines CorporationCompletedGISTUnited States, Korea, Republic of, Netherlands, China, France, Spain, Italy, Belgium, United Kingdom, Singapore, Australia, Canada, Germany, Sweden, Hungary, Austria, Czechia, Poland
-
Blueprint Medicines CorporationCompletedGastrointestinal Stromal Tumors (GIST) | Other Relapsed or Refractory Solid TumorsUnited States, United Kingdom, France, Korea, Republic of, Belgium, Germany, Italy, Netherlands, Poland, Spain
-
Blueprint Medicines CorporationApproved for marketingNon-Small Cell Lung Cancer | Medullary Thyroid Cancer
-
Blueprint Medicines CorporationRecruitingGastric Cancer | Ovarian Cancer | Carcinosarcoma | Advanced Solid Tumors | Endometrial Cancer | Esophageal Adenocarcinoma | HER2-negative Breast Cancer | CCNE1 Amplification | HR+ Breast CancerUnited States, Italy, United Kingdom
-
Blueprint Medicines CorporationRecruitingIndolent Systemic Mastocytosis | Monoclonal Mast Cell Activation SyndromeUnited States, Spain, Australia, France, Netherlands, Switzerland, Norway, United Kingdom, Austria, Belgium, Germany, Italy, Portugal
-
Blueprint Medicines CorporationCompletedGastrointestinal Stromal Tumors | GIST | Non-resectable Advanced Solid Tumors | Recurrent or Unresectable Central Nervous System (CNS) TumorsUnited States
-
Blueprint Medicines CorporationActive, not recruitingMast Cell Leukemia | Aggressive Systemic Mastocytosis | Advanced Systemic Mastocytosis | Systemic Mastocytosis With an Associated Hematologic NeoplasmUnited States, Canada, United Kingdom, France, Netherlands, Italy, Spain, Austria, Denmark, Germany, Norway, Poland
-
Blueprint Medicines CorporationActive, not recruitingGastrointestinal Stromal TumorsFrance
-
Blueprint Medicines CorporationApproved for marketing
-
Blueprint Medicines CorporationRecruitingAdvanced Systemic MastocytosisUnited States, Norway, Netherlands, Belgium, Germany, France, Spain
-
Blueprint Medicines CorporationCompletedHepatocellular Carcinoma (HCC)China, Korea, Republic of, Taiwan, Hong Kong, United Kingdom, United States, France, Spain, Switzerland, Singapore, Germany, Italy
-
Blueprint Medicines CorporationActive, not recruitingNeoplasms | Neoplasms by Histologic Type | Lung Diseases | Neoplasms by Site | Adenocarcinoma | Carcinoma | Carcinoma, Non-Small-Cell Lung | Respiratory Tract Neoplasms | Carcinoma, Bronchogenic | Bronchial Neoplasms | Metastatic Lung Cancer | Antineoplastic Agents | Brain Metastases | Lung Neoplasm Malignant | EGFR... and other conditionsUnited States, Canada, Korea, Republic of, Japan, Taiwan
-
Blueprint Medicines CorporationActive, not recruitingNeoplasms | Neoplasms by Histologic Type | Lung Diseases | Neoplasms by Site | Adenocarcinoma | Carcinoma | Carcinoma, Non-Small-Cell Lung | Lung Neoplasms | Respiratory Tract Neoplasms | Thoracic Neoplasms | Carcinoma, Bronchogenic | Bronchial Neoplasms | Neoplasms, Nerve Tissue | EGF-R Positive Non-Small Cell Lung... and other conditionsUnited States, Canada, Taiwan, Korea, Republic of, Singapore, Japan, United Kingdom, France, Netherlands, Spain
-
Blueprint Medicines CorporationCompletedSystemic Mast Cell Activation | KIT D816V MutationUnited States, France, United Kingdom, Italy, Germany, Belgium, Spain, Switzerland
-
Blueprint Medicines CorporationCompletedHealthy VolunteersUnited States
-
EpicentreMedecins Sans Frontieres, NetherlandsWithdrawn
-
EpicentreMedecins Sans Frontieres, NetherlandsCompletedEbola Virus DiseaseUganda, Congo, The Democratic Republic of the
-
EpicentreMedecins Sans Frontieres, NetherlandsCompletedSevere Acute Malnutrition
-
EpicentreMedecins Sans Frontieres, SpainWithdrawnChild | Malnutrition | Malaria, FalciparumNiger
-
EpicentreMedecins Sans Frontieres, SpainCompletedMalaria, FalciparumCongo, The Democratic Republic of the
-
Link Medicine CorporationCompleted
-
Link Medicine CorporationCompleted
-
Karolinska InstitutetMedecins Sans Frontieres, NetherlandsCompletedWounds and Injuries | Leg Injuries | Soft Tissue Injuries | Wound Infection | Arm Injuries | Wounds, Penetrating | Wounds, Gunshot | War-Related InjuriesJordan
-
Blueprint Medicines CorporationPatientCrossroadsCompleted
-
EpicentreBrown University; Medecins Sans Frontieres, NetherlandsWithdrawnFracture | Lower Limb Injuries
-
Medicis Pharmaceutical CorporationCompletedHuman VolunteerUnited States
-
Medicis Technologies CorporationCompleted
-
EpicentreMedecins Sans Frontieres, Netherlands; Ipas; Guttmacher InstituteActive, not recruitingAbortion ComplicationCentral African Republic, Congo, The Democratic Republic of the, Nigeria
-
Genentech, Inc.Blueprint Medicines CorporationRecruitingNon-small Cell Lung CancerUnited States
-
CStone PharmaceuticalsBlueprint Medicines CorporationCompletedGastrointestinal Stromal TumorsChina